Daniel Oliva Laucirica
CEO

The startup has developed an AI-powered pulmonology care system that continuously monitors over 40 parameters to customize long-term oxygen therapy in real-time. This technology enables healthcare providers to enhance the management of patients with chronic obstructive pulmonary disease by delivering precise and adaptive treatment solutions.
Raised to date
$520KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.